drugset

drugset / Trial / NCT02095574

A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's Lymphoma

NCT02095574 ↗

Phase 1 Withdrawn AbbVie Genentech, Inc. · collab

NaSingle-groupOpen-labelBasic science

Summary

A pharmacokinetic study to access how the body absorbs and removes ABT-199 in adults with Non-Hodgkin's Lymphoma.

Timeline

Start: 2014-09
Primary completion: 2014-09
Completion: 2015-01

Outcome

Outcome not reported

Stopped: “This study will now be conducted in healthy volunteers.”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Venetoclax	Small molecule	—	Oral

Indications